MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Speech disorders and axial motor impairment in advanced Parkinson’s Disease: two sides of the same coin?

    G. Di Rauso, C. Budriesi, F. Cavallieri, A. Gessani, S. Coniglio, V. Rispoli, F. Valzania, F. Antonelli (Modena, Italy)

  • Speech markers of Presymptomatic and Prodromal Huntington’s disease

    A. Vogel, C. Chan, G. Stuart, P. Maruff, Y. Lie, J. Stout (Melbourne, Australia)

  • Spinal cord stimulation for gait problems in Parkinson´s disease: Long term report and placebo viability

    R. Carra, J. Menezes, T. Capato, K. Duarte, R. Cury (Sao Paulo, Brazil)

  • Spinocerebellar ataxia 21 and phenotypic variability within a family

    M. Hull, M. Parnes, J. Jankovic (Houston, USA)

  • Spinocerebellar Ataxia Type 5: an Unusual Infantile Onset with Development Delay

    S. Gallo, L. Magistrelli, E. Contaldi, I C. Campini, R. Cantello, C. Comi (Novara, Italy)

  • Sporadic progressive ataxia and palatal tremor: a case series

    A. Fuentes, I. Bledsoe, C. Dietiker, J. Maas, E. Brown (San Francisco, USA)

  • Statin use and incidence of Parkinson’s disease in women from the French E3N cohort study

    TTH. Nguyen, A. Fournier, E. Courtois, F. Artaud, S. Escolano, P. Tubert-Bitter, MC. Boutron-Ruault, I. Degaey, E. Roze, M. Canonico, I. Ahmed, ACM. Thiébaut, A. Elbaz (Villejuif, France)

  • Status Update of EPSILON: a Phase III, Randomised, Placebo-Controlled Study of Opicapone in Early Parkinson’s Disease

    J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, J. Moreira, J-F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

  • STN-DBS Targeting SNr Modulates Sleep in Parkinson’s Disease: A Proof-of-Concept Study

    HL. Yu, LX. Guan, YN. Sui, F. Ba, LM. Li (Beijing, China)

  • Striatal Blood brain barrier opening in Parkinson´s disease

    C. Gasca-Salas, J. Pineda-Pardo, B. Fernández-Rodríguez, I. Obeso, F. Hernández-Fernández, C. Trompeta, R. Martínez-Fernández, M. Matarazzo, D. Mata-Marín, P. Guida, G. Foffani, G. Toltsis, I. Rachmilevitch, J. Blesa, R. Rodríguez-Rojas, M. Del-Alamo, J. Obeso (Móstoles, Spain)

  • « Previous Page
  • 1
  • …
  • 127
  • 128
  • 129
  • 130
  • 131
  • …
  • 153
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley